Related Experiment Video
Updated: Feb 12, 2026

High-throughput Screening of Chemical Compounds to Elucidate Their Effects on Bacterial Persistence
Published on: February 23, 2021
A new class of synthetic retinoid antibiotics effective against bacterial persisters
Wooseong Kim1, Wenpeng Zhu2, Gabriel Lambert Hendricks1
1Division of Infectious Diseases, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island 02903, USA.
Abstract:
A challenge in the treatment of Staphylococcus aureus infections is the high prevalence of methicillin-resistant S. aureus (MRSA) strains and the formation of non-growing, dormant 'persister' subpopulations that exhibit high levels of tolerance to antibiotics and have a role in chronic or recurrent infections. As conventional antibiotics are not effective in the treatment of infections caused by such bacteria, novel antibacterial therapeutics are urgently required. Here we used a Caenorhabditis elegans-MRSA infection screen to identify two synthetic retinoids, CD437 and CD1530, which kill both growing and persister MRSA cells by disrupting lipid bilayers. CD437 and CD1530 exhibit high killing rates, synergism with gentamicin, and a low probability of resistance selection. All-atom molecular dynamics simulations demonstrated that the ability of retinoids to penetrate and embed in lipid bilayers correlates with their bactericidal ability. An analogue of CD437 was found to retain anti-persister activity and show an improved cytotoxicity profile. Both CD437 and this analogue, alone or in combination with gentamicin, exhibit considerable efficacy in a mouse model of chronic MRSA infection. With further development and optimization, synthetic retinoids have the potential to become a new class of antimicrobials for the treatment of Gram-positive bacterial infections that are currently difficult to cure.
Insights
New synthetic retinoids, CD437 and CD1530, effectively kill growing and dormant methicillin-resistant Staphylococcus aureus (MRSA) cells. These compounds show promise as novel antimicrobials against persistent bacterial infections.
Area of Science:
- Microbiology
- Drug Discovery
- Molecular Biology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant treatment challenge due to antibiotic tolerance in dormant persister cells.
- Conventional antibiotics are ineffective against these persister cells, necessitating the development of novel antibacterial agents.
Purpose of the Study:
- To identify novel therapeutics effective against both growing and persister MRSA cells.
- To explore the potential of synthetic retinoids as a new class of antimicrobials.
Main Methods:
- Utilized a Caenorhabditis elegans-MRSA infection screen to identify potential drug candidates.
- Employed all-atom molecular dynamics simulations to understand the mechanism of action.
- Evaluated drug efficacy in a mouse model of chronic MRSA infection.
Main Results:
- Identified two synthetic retinoids, CD437 and CD1530, that kill both growing and persister MRSA by disrupting lipid bilayers.
- Demonstrated synergism with gentamicin and a low probability of resistance selection for these retinoids.
- An optimized analogue of CD437 showed retained anti-persister activity with improved cytotoxicity and efficacy in a mouse model.
Conclusions:
- Synthetic retinoids, such as CD437 and CD1530, represent a promising new class of antimicrobials against difficult-to-treat Gram-positive bacterial infections.
- These compounds effectively target both growing and dormant MRSA, offering a potential solution for chronic and recurrent infections.
- Further development of synthetic retinoids could lead to novel treatments for persistent bacterial infections.
Related Concept Videos
Antibiotic Selection
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Drug Classes and Categories
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Synthetic Disvision of Polynomials

